172 related articles for article (PubMed ID: 17939339)
21. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
22. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?
Kim WS; Song SY; Ahn YC; Ko YH; Baek CH; Kim DY; Yoon SS; Lee HG; Kang WK; Lee HJ; Park CH; Park K
Ann Oncol; 2001 Mar; 12(3):349-52. PubMed ID: 11332147
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
Suzuki R; Suzumiya J; Yamaguchi M; Nakamura S; Kameoka J; Kojima H; Abe M; Kinoshita T; Yoshino T; Iwatsuki K; Kagami Y; Tsuzuki T; Kurokawa M; Ito K; Kawa K; Oshimi K;
Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
[TBL] [Abstract][Full Text] [Related]
24. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
25. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Pinnix CC; Dabaja B; Ahmed MA; Chuang HH; Costelloe C; Wogan CF; Reed V; Romaguera JE; Neelapu S; Oki Y; Rodriguez MA; Fayad L; Hagemeister FB; Nastoupil L; Turturro F; Fowler N; Fanale MA; Nieto Y; Khouri IF; Ahmed S; Medeiros LJ; Davis RE; Westin J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):113-21. PubMed ID: 25863759
[TBL] [Abstract][Full Text] [Related]
26. Nasal NK/T-cell lymphoma in the paediatric population. Two case reports.
Zeglaoui I; Belcadhi M; Sriha B; Bouzouita K
B-ENT; 2009; 5(2):119-23. PubMed ID: 19670600
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of nasal type NK/T cell lymphoma presenting as neurolymphomatosis on 18F-FDG PET/CT: A case report and literature review.
Pan Q; Luo Y
Medicine (Baltimore); 2020 Jan; 99(1):e18640. PubMed ID: 31895825
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and treatment of a patient with primary gastric extranodal natural killer/T-cell lymphoma, nasal type.
Yang H; Wu M; Yin W; Sun W; Zhang G
Leuk Lymphoma; 2010 Nov; 51(11):2137-40. PubMed ID: 20858103
[No Abstract] [Full Text] [Related]
29. [Case series of localized nasal NK/T-cell lymphoma treated with preceding intensified local radiation therapy before systemic chemotherapy].
Tamai Y; Imataki O; Abe Y; Hagiwara S; Ito I; Asakura H; Harada H; Kamata M; Nishimura T; Kawakami K
Gan To Kagaku Ryoho; 2006 May; 33(5):687-90. PubMed ID: 16685174
[TBL] [Abstract][Full Text] [Related]
30. Primary NK/T-cell lymphoma of the larynx.
Uri N; Schindler Y; Quitt M; Valkovsky O; Barzilai G
Ear Nose Throat J; 2012 May; 91(5):206-7. PubMed ID: 22614556
[TBL] [Abstract][Full Text] [Related]
31. Deceptive nasal NK/T-cell lymphoma.
Thakur JS; Mahajan A; Saluja M; Mohindroo NK
Trop Doct; 2017 Jul; 47(3):268-271. PubMed ID: 28689491
[TBL] [Abstract][Full Text] [Related]
32. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
Liang R
Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
34. Natural Killer (NK)//T-Cell Lymphoma, Nasal Type, with Periorbital Involvement: A Case Report and Literature Review.
Lisowska G; Zięba N; Stryjewska-Makuch G; Ścierski W; Miśkiewicz-Orczyk K; Misiołek M
Am J Case Rep; 2020 Sep; 21():e926599. PubMed ID: 32956336
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation.
Mori Y; Aoki T; Takenaka K; Yamauchi T; Yamamoto A; Kamezaki K; Iwasaki H; Harada N; Miyamoto T; Nagafuji K; Teshima T; Akashi K
Int J Hematol; 2010 Jan; 91(1):107-11. PubMed ID: 19949902
[TBL] [Abstract][Full Text] [Related]
36. Current management of nasal NK/T-cell lymphoma.
Au WY
Oncology (Williston Park); 2010 Apr; 24(4):352-8. PubMed ID: 20464847
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R
Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma].
Yao B; Li YX; Fang H; Yu ZH; Jin J; Liu XF
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):222-5. PubMed ID: 16875550
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
40. [Relapse in the nasal cavity of a patient with extranodal NK/T-cell lymphoma initially presenting as plantar subcutaneous tumor].
Sakaguchi H; Miyazaki K; Tono Y; Fujieda A; Nakamori Y; Mizutani M; Sekine T; Shibazaki T; Oka K; Katou K; Monma F; Yamaguchi M; Masuya M; Katayama N
Rinsho Ketsueki; 2015 Aug; 56(8):1076-81. PubMed ID: 26345570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
